Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells

Genome Biology

Volumn 4, Issue 12, 2003, Pages

  Lee, Jae K ^a,b   Bussey, Kimberly J ^a   Gwadry, Fuad G ^a   Reinhold, William ^a   Riddick, Gregory ^b   Pelletier, Sandra L ^b   Nishizuka, Satoshi ^a   Szakacs, Gergely ^a   Annereau, Jean Phillipe ^a   Shankavaram, Uma ^a   Lababidi, Samir ^a   Smith, Lawrence H ^a   Gottesman, Michael M ^a   Weinstein, John N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Additional Data File; cDNA Array; Correlation Screening; Oligo Array; UniGene Cluster

Indexed keywords

ALGORITHM; ARTICLE; CLUSTER ANALYSIS; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METHODOLOGY; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 1542577328     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2003-4-12-r82     Document Type: Article

References (29)

1. Boyd MR, Paull KD: Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res. 1995, 34: 91-109. DOI: 10.1002/ddr.430340203
2. Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, Plowman J, Boyd MR: Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst. 1989, 81: 1088-1092. 10.1093/jnci/81.14.1088. DOI: 10.1093/jnci/81.14.1088
3. Weinstein JN, Kohn KW, Grever MR, Viswanadhan VN, Rubinstein LV, Monks AP, Scudiero DA, Welch L, Koutsoukos AD, Chiausa AJ, et al: Neural computing in cancer drug development: predicting mechanism of action. Science. 1992, 258: 447-451. DOI: 10.1126/science.1411538
4. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, et al: An information-intensive approach to the molecular pharmacology of cancer. Science. 1997, 275: 343-349. 10.1126/science.275.5298.343. DOI: 10.1126/science.275.5298.343
5. Shi LM, Fan Y, Lee JK, Waltham M, Andrews DT, Scherf U, Paull KD, Weinstein JN: Mining and visualizing large anticancer drug databases. J Chem Inf Comput Sci. 2000, 40: 367-379. 10.1021/ci990087b. DOI: 10.1021/ci990087b
6. Rabow AA, Shoemaker RH, Sausville EA, Covell DG: Mining the National Cancer Institute's drug screening database: identification of compounds with similar cellular activities. J Med Chem. 2002, 45: 818-840. 10.1021/jm010385b. DOI: 10.1021/jm010385b
7. Wu L, Smythe AM, Stinson SF, Mullendore LA, Monks A, Scudiero DA, Paull KD, Koutsoukos AD, Rubinstein LV, Boyd MR, et al: Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res. 1992, 52: 3029-3034.
8. Bates SE, Fojo AT, Weinstein JN, Myers TG, Alvarez M, Pauli KD, Chabner BA: Molecular targets in the National Cancer Institute drug screen. J Cancer Res Clin Oncol. 1995, 121: 495-500. DOI: 10.1007/BF01197759
9. Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S, Fojo T: Generation of a drug resistance profile by quantitation of MDR-1/P-glycoprotein expression in the cell lines of the NCI anticancer drug screen. J Clin Invest. 1995, 95: 2205-2214. DOI: 10.1172/JCI117910
10. Koo HM, Monks A, Mikheev A, Rubinstein LV, Gray-Goodrich M, McWilliams MJ, Alvord WG, Oie HK, Gazdar AF, Paull KD, et al: Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res. 1996, 56: 5211-5216.
11. Myers TG, Anderson NL, Waltham M, Li G, Buolamwini JK, Scudiero DA, Paull KD, Sausville EA, Weinstein JN, et al: A protein expression database for the molecular pharmacology of cancer. Electrophoresis. 1997, 18: 647-653. DOI: 10.1002/elps.1150180351
12. O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, et al: Characterization of the p53-tumor suppressor pathway in cells of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 1997, 57: 4285-4300.
13. Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K, Steeg PS, et al: Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. Nat Med. 1997, 3: 395-401. DOI: 10.1038/nm0497-395
14. Wosikowski K, Schuurhuis D, Johnson K, Paull KD, Myers TG, Weinstein JN, Bates SE: Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns. J Natl Cancer Inst. 1997, 89: 1505-1513. 10.1093/jnci/89.20.1505. DOI: 10.1093/jnci/89.20.1505
15. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, et al: A gene expression database for the molecular pharmacology of cancer. Nat Genet. 2000, 24: 236-244. 10.1038/73439. DOI: 10.1038/73439
16. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, et al: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000, 24: 227-235. 10.1038/73432. DOI: 10.1038/73432
17. Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, et al: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA. 2001, 98: 10787-10792. 10.1073/pnas.191368598. DOI: 10.1073/pnas.191368598
18. Shao J, Tu D: The Jackknife and Bootstrap. 1995, New York: Springer DOI: 10.1007/978-1-4612-0795-5
19. Warren RA, Green FA, Stenberg PE, Enns CA: Distinct saturable pathways for the endocytosis of different tyrosine motifs. J Biol Chem. 1998, 273: 17056-17063. 10.1074/jbc.273.27.17056. DOI: 10.1074/jbc.273.27.17056
20. ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K: Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene. 1993, 8: 2879-2887.
21. Hofmann UB, Westphal JR, van Muijen GNP, Ruiter DJ: Matrix metalloproteinases in human melanoma. J Invest Dermatol. 2000, 115: 337-344. 10.1046/j.1523-1747.2000.00068.x. DOI: 10.1046/j.1523-1747.2000.00068.x
22. Genomics and Bioinformatics Group at the Laboratory of Molecular Pharmacology, National Cancer Institute. [http://discover.nci.nih.gov]
23. Kuo WP, Jenssen TK, Butte AJ, Ohno-Machado L, Kohane IS: Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics. 2002, 18: 405-412. 10.1093/bioinformatics/18.3.405. DOI: 10.1093/bioinformatics/18.3.405
24. Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, Reinhold WC, Waltham M, Charboneau L, Young L, et al: Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res. 2003, 63: 5243-5250.
25. Reissig D, Clement J, Sanger J, Berndt A, Kosmehl H, Bohmer FD: Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. J Cancer Res Clin Oncol. 2001, 127: 226-230. 10.1007/s004320000197. DOI: 10.1007/s004320000197
26. Silverman BW: Density Estimation for Statistics and Data Analysis. 1986, London: Chapman and Hall DOI: 10.1007/978-1-4899-3324-9
27. Affymetrix. [http://www.affymetrix.com]
28. Zhuo D, Zhao WD, Wright FA, Yang HY, Wang JP, Sears R, Baer T, Kwon DH, Gordon D, Gibbs S, et al: Assembly, annotation, and integration of UNIGENE clusters into the human genome draft. Genome Res. 2001, 11: 904-918. 10.1101/gr.GR-1645R. DOI: 10.1101/gr.GR-1645R
29. Bussey K, Kane D, Sunshine M, Narasimhan S, Nishizuka S, Reinhold W, Zeeberg B, Ajay, Weinstein J: MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol. 2003, 4: R27-10.1186/gb-2003-4-4-r27. DOI: 10.1186/gb-2003-4-4-r27